Sponsored
Lessons from the COVID-19 response highlight regulatory collaboration, research expansion, and challenges in vaccine access and preparedness.
A lot can be learned from the COVID-19 response, including global regulatory collaboration, de-risking pharmaceutical development, and expanding research participation. This segment covers challenges such as sustaining preparedness and addressing vaccine access inequities.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.